In Brief: Sunrise Medical
This article was originally published in The Gray Sheet
Executive SummarySunrise Medical: Completes $6.5 mil. sale of the air therapy rental business of its Bio Clinic division to a joint venture between Mediq PRN and Huntleigh Technology subsidiary HNE Rentals. Under terms of the deal, Mediq PRN/HNE obtains the rental business' inventories and fixed assets, as well as most of its personnel, and agrees to certain purchases of Bio Clinic products over the next three years. The air therapy service unit had $12 mil. in sales in fiscal 1995...
You may also be interested in...
The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.
Cadila has filed for approval of saroglitazar for NASH in India. The drug, which could emerge as the first medicine for the indication if approved, is already being used by a million Indian patients for diabetic dyslipidemia and hypertriglyceridemia.
It has been a long and sometimes tortuous development path for Lupuzor but ImmuPharma's chief executive tells Scrip the company's faith in the lupus drug is bearing fruit.